Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Invitrogen™ UGT1A5 Polyclonal Antibody
Rabbit Polyclonal Antibody
Supplier: Invitrogen™ PA543353
Description
Peptide sequence: EENFFTLTTY AISWTQDEFD RLLLGHTQSF FETEHLLMKF SRRMAIMNNM Sequence homology: Human: 100%; Rat: 83%.
This gene encodes a UDP-glucuronosyltransferase, an enzyme of the glucuronidation pathway that transforms small lipophilic molecules, such as steroids, bilirubin, hormones, and drugs, into water-soluble, excretable metabolites. This gene is part of a complex locus that encodes several UDP-glucuronosyltransferases. The locus includes thirteen unique alternate first exons followed by four common exons. Four of the alternate first exons are considered pseudogenes. Each of the remaining nine 5' exons may be spliced to the four common exons, resulting in nine proteins with different N-termini and identical C-termini. Each first exon encodes the substrate binding site, and is regulated by its own promoter.
Specifications
UGT1A5 | |
Polyclonal | |
Unconjugated | |
UGT1A5 | |
B5; GNT1; UDP glucuronosyltransferase 1 family, polypeptide A5; UDP glucuronosyltransferase family 1 member A5; UDP glycosyltransferase 1 family, polypeptide A5; UDP-glucuronosyltransferase 1 family polypeptide A5s; UDP-glucuronosyltransferase 1-5; UDP-glucuronosyltransferase 1A5; UDP-glucuronosyltransferase 1-E; UDPGT; UDPGT 1-5; Ugt1; UGT1*5; UGT1.5; UGT1-05; UGT1A5; Ugt1a6; UGT1E; UGT-1E | |
Rabbit | |
Affinity Chromatography | |
RUO | |
54579 | |
-20°C, Avoid Freeze/Thaw Cycles | |
Liquid |
Western Blot | |
0.5 mg/mL | |
PBS with 2% sucrose and 0.09% sodium azide | |
P35504 | |
UGT1A5 | |
Synthetic peptide directed towards the N-terminal of human UGT1A5 (aa 71-120). | |
100 μL | |
Primary | |
Human | |
Antibody | |
IgG |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction